Claraphi Advisory Network’s CVS Health CVS Stock Holding History

Claraphi Advisory Network’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$682K	Sell	7,320 -9,424	-56%	-$909K	0.27%	101
2022 Q3	$1.6M	Buy	16,744 +51	+0.3%	+$5.05K	0.86%	23
2022 Q2	$1.55M	Sell	16,693 -2,467	-13%	-$241K	0.54%	39
2022 Q1	$1.94M	Sell	19,160 -1,667	-8%	-$175K	0.56%	38
2021 Q4	$2.15M	Sell	20,827 -931	-4%	-$86K	0.75%	29
2021 Q3	$1.85M	Buy	21,758 +189	+0.9%	+$15.8K	0.65%	29
2021 Q2	$1.8M	Buy	21,569 +101	+0.5%	+$8.27K	0.54%	33
2021 Q1	$1.61M	Sell	21,468 -21	-0.1%	-$1.53K	0.45%	37
2020 Q4	$1.47M	Sell	21,489 -715	-3%	-$46.5K	0.4%	42
2020 Q3	$1.3M	Buy	22,204 +15,152	+215%	+$943K	0.47%	37
2020 Q2	$458K	Buy	7,052 +164	+2%	+$10.3K	0.2%	108
2020 Q1	$409K	Buy	6,888 +182	+3%	+$12.2K	0.19%	100
2019 Q4	$498K	Buy	6,706 +2,937	+78%	+$206K	0.3%	76
2019 Q3	$238K	Buy	+3,769	New	+$223K	0.14%	163
2018 Q3	–	Sell	-3,277	Closed	-$211K	–	264
2018 Q2	$211K	Buy	+3,277	New	+$216K	0.14%	229

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Claraphi Advisory Network's CVS Position: Q4 2022 in Review

Claraphi Advisory Network reduced its CVS Health (CVS) stake by 56% in Q4 2022, selling an estimated $909K and leaving 7,320 shares worth $682K. The position accounts for 0.27% of the portfolio, ranked #101.

Claraphi Advisory Network first reported a position in CVS in Q2 2018 and has held it in 15 quarters since. The position peaked at $2.15M in Q4 2021. 2,406 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

Claraphi Advisory Network held 7,320 shares of CVS Health worth $682K as of Q4 2022.
Claraphi Advisory Network sold 9,424 CVS Health shares in Q4 2022, an estimated $909K.
CVS Health made up 0.27% of Claraphi Advisory Network's portfolio in Q4 2022, its #101 holding.
Claraphi Advisory Network first reported a position in CVS Health in Q2 2018 and has held it in 15 quarters since.
Claraphi Advisory Network's CVS Health position peaked at $2.15M in Q4 2021.
2,406 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Claraphi Advisory Network's 13F filing for Q4 2022, filed 14 Feb 2023.